China Market Intelligence

August 7th, 2019
By USCBC Staff

On July 31, US-China Business Council (USCBC) President Craig Allen testified before the US-China Economic Security Review Commission (USCC) on US companies’ access, risks, and opportunities in China’s health market.

January 16th, 2019
By Chynna Hawes

Draft amendments make some progress in strengthening China’s intellectual property rights (IPR) system, including by increasing penalties, extending patent term for designs, and adding patent term restoration for innovative pharmaceuticals.

November 7th, 2018
By Anna Ashton

The US-China Business Council (USCBC) and several other trade associations submitted joint comments on provisions regarding personal information and data privacy protection in China’s

September 20th, 2018
By Jake Parker

As summer draws to a close, I would like to highlight a few trends USCBC’s China offices are observing based on their conversations with our membership, Chinese media, government sources, and other key influencers.

June 28th, 2018

President Donald Trump has decided against using much-anticipated new measures to restrict Chinese access to US technology and instead will use existing tools, according to a White Hou

May 30th, 2018
By Jake Laband and Anna Ashton

Although the denial order recently brought by the U.S.

May 2nd, 2018
By USCBC Staff

Following two years of decline, the United States exported more goods in 2017 to China than ever before– in excess of $127 billion. China also continues to be a major growth market for US services exports, and is virtually tied with Canada as the second-largest services market for the United States.

December 13th, 2017
By Owen Haacke

Despite indications that US companies expect growth in revenue and profitability next year in China, concern about possible trade actions was evident  in polling USCBC members who attended the Shanghai China Operations Conference on November 30.

October 25th, 2017
By David Solomon

The US-China Business Council (USCBC) recently submitted comments to the China Food and Drug Administration (CFDA) on the

May 11th, 2015
Ryan Ong

Despite progress on competition concerns at the December 2014 Joint Commission on Commerce and Trade (JCCT) meeting, competition enforcement under the Antimonopoly Law (AML) remains a high-profile concern for many US companies in China.

Pages

Phase One Tracker

We are tracking over 150 commitments—several of which had never been offered before—on items ranging from market access to improving intellectual property rights protection and administrative reforms. 

LEARN MORE